+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Generic Injectables Market by Dimension Query Chat Segmentation (Distribution Channel, Dosage Form, Drug Class) - Global Forecast 2025-2030- Product Image
Generic Injectables Market by Dimension Query Chat Segmentation (Distribution Channel, Dosage Form, Drug Class) - Global Forecast 2025-2030- Product Image
Sale

Generic Injectables Market by Dimension Query Chat Segmentation (Distribution Channel, Dosage Form, Drug Class) - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887534
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The generic injectables market is advancing rapidly as healthcare systems and pharmaceutical manufacturers seek to deliver accessible, affordable, and effective therapies across global regions. Decision-makers must adapt to dynamic regulatory frameworks, supply chain shifts, and new technologies, strategically positioning themselves for success in this high-growth segment.

Market Snapshot: Growth Trajectory in Generic Injectables

The Generic Injectables Market grew from USD 36.58 billion in 2024 to USD 40.64 billion in 2025. It is expected to continue growing at a CAGR of 10.69%, reaching USD 67.30 billion by 2030. This upward trend is underpinned by the rising need for cost-effective, high-quality injectable therapies. Patent expiries, a strategic focus on generics, and the adoption of modern manufacturing and packaging technologies further fuel this market’s expansion. Advancement in regulatory harmonization and manufacturing scalability ensures continued market resilience and a diversified pipeline.

Scope & Segmentation of the Generic Injectables Market

This report delivers in-depth analysis and segmentation tailored for executive strategy formulation. The following key areas capture the breadth of the sector's evolution:

  • Distribution Channels: Direct tender, hospital pharmacy distribution, online B2C platforms, e-pharmacies, and retail distribution.
  • Dosage Forms: Emulsion, lyophilized powder, solution, and suspension.
  • Drug Classes: Analgesics, anesthetics, antibiotics (aminoglycosides, beta-lactams, glycopeptides), cardiovascular agents, and oncology agents (cytotoxics, monoclonal antibodies).
  • End Users: Ambulatory surgical centers, community and specialty clinics, hospital pharmacies, and retail pharmacies.
  • Large Volume Parenterals: Bags and bottles.
  • Molecules: Cefuroxime, fentanyl, meropenem, oxaliplatin, vancomycin.
  • Packaging Types: Ampoules, cartridges, pre-filled syringes (safety and standard), vials.
  • Product Types: Ampoule, pre-filled syringe (safety and standard), vial.
  • Routes of Administration: Intramuscular, intravenous, subcutaneous.
  • Therapeutic Applications: Anesthesia, anti-infective (antibiotics, antivirals), cardiovascular, oncology (cytotoxic, targeted therapies), pain management (opioids, non-opioids).
  • Regional Coverage: Americas (USA, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (multiple countries), and Asia-Pacific (major markets including China, India, Japan, Australia, and Southeast Asia).
  • Company Profiles: Fresenius Kabi AG, Baxter International Inc., Pfizer Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Limited, Hikma Pharmaceuticals PLC, Viatris Inc., Amneal Pharmaceuticals Inc., Aspen Pharmacare Holdings Limited, Recipharm AB.

Key Takeaways for Senior Decision-Makers

  • Transition to continuous manufacturing and automation accelerates time-to-market, ensuring consistent product quality and improved operational agility in the generic injectables sector.
  • Digital supply chain solutions and advanced analytics support demand forecasting, inventory optimization, and real-time logistics management across global distribution networks.
  • Regulatory harmonization is enabling faster submissions while reducing duplicative requirements, with mutual recognition agreements facilitating cross-border market entry and nearshoring.
  • Patient-centric delivery formats, such as safety-engineered pre-filled syringes and on-body systems, are increasing adoption and adherence across both hospital and home care settings.
  • Segmented strategies in dosage forms and therapeutic applications reflect growing complexity, with demand surging in oncology and anti-infective categories due to stewardship protocols and rising patient acuity.
  • Strategic partnerships in manufacturing and distribution—including local alliances and digital logistics investments—allow for resilient sourcing and tailored commercial models across regions with varying infrastructure and regulatory requirements.

Tariff Impact on Cost Structures and Supply Chains

New United States tariff regulations, effective in 2025, introduce added complexity for generic injectable manufacturers by imposing duties on select active ingredients and packaging materials. To counter potential supply disruptions and cost fluctuations, many producers are expanding nearshore manufacturing and diversifying procurement strategies. Hospital and retail distribution channels must carefully calibrate inventory and service levels to maintain uninterrupted patient access and optimize working capital.

Methodology & Data Sources

This analysis is grounded in primary research, incorporating expert interviews and structured questionnaires with hospital formulary managers, procurement leaders, and regulatory professionals. Comprehensive secondary research draws on regulatory filings, technical reports, international policy documents, and proprietary industry databases. Data triangulation and expert panel review ensure actionable, reliable conclusions.

Why This Report Matters

  • Executives are equipped with strategic insights to anticipate supply chain and regulatory shifts in the generic injectables market, strengthening decision-making agility.
  • Operational benchmarking enables organizations to assess their competitive posture and prioritize investment in technology, packaging, and new market entry.
  • Clear segmentation perspectives and global context empower leaders to tailor go-to-market strategies and product portfolios for optimal impact.

Conclusion

The generic injectables market presents evolving challenges and robust opportunities for stakeholders committed to innovation and efficiency. By leveraging this intelligence, senior decision-makers can strategically position their organizations to drive sustained growth and operational excellence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of biosimilar insulin analogues driving cost competitiveness in diabetes management
5.2. Integration of digital health platforms with injectable medication adherence tracking for improved patient outcomes
5.3. Rising demand for on-body delivery systems enabling self-administration of complex biologic injectables
5.4. Expansion of emerging markets through strategic partnerships to localize generic injectable manufacturing capacity
5.5. Shift towards prefilled syringes and safety-engineered devices to minimize dosing errors and needlestick injuries
5.6. Regulatory harmonization initiatives accelerating approval timelines for generic injectable oncology treatments
5.7. Strategic acquisitions by CDMOs to meet surging global demand for high-potency injectable manufacturing capacity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Generic Injectables Market, by Dimension Query Chat Segmentation
8.1. Introduction
8.2. Distribution Channel
8.2.1. Direct Tender
8.2.2. Hospital Pharmacy Distribution
8.2.3. Online Distribution
8.2.3.1. B2C Platforms
8.2.3.2. E-Pharmacies
8.2.4. Retail Distribution
8.3. Dosage Form
8.3.1. Emulsion
8.3.2. Lyophilized Powder
8.3.3. Solution
8.3.4. Suspension
8.4. Drug Class
8.4.1. Analgesics
8.4.2. Anesthetics
8.4.3. Antibiotics
8.4.3.1. Aminoglycosides
8.4.3.2. Beta-Lactams
8.4.3.3. Glycopeptides
8.4.4. Cardiovascular Agents
8.4.5. Oncology Agents
8.4.5.1. Cytotoxics
8.4.5.2. Monoclonal Antibodies
8.5. End User
8.5.1. Ambulatory Surgical Centers
8.5.2. Clinics
8.5.2.1. Community Clinics
8.5.2.2. Specialty Clinics
8.5.3. Hospital Pharmacies
8.5.4. Retail Pharmacies
8.6. Large Volume Parenteral
8.6.1. Bag
8.6.2. Bottle
8.7. Molecule
8.7.1. Cefuroxime
8.7.2. Fentanyl
8.7.3. Meropenem
8.7.4. Oxaliplatin
8.7.5. Vancomycin
8.8. Packaging Type
8.8.1. Ampoules
8.8.2. Cartridges
8.8.3. Pre-Filled Syringes
8.8.3.1. Safety Syringes
8.8.3.2. Standard Syringes
8.8.4. Vials
8.9. Product Type
8.9.1. Ampoule
8.9.2. Pre-Filled Syringe
8.9.2.1. Safety Syringe
8.9.2.2. Standard Syringe
8.9.3. Vial
8.10. Route Of Administration
8.10.1. Intramuscular
8.10.2. Intravenous
8.10.3. Subcutaneous
8.11. Therapeutic Application
8.11.1. Anesthesia
8.11.2. Anti-Infective
8.11.2.1. Antibiotics
8.11.2.2. Antivirals
8.11.3. Cardiovascular
8.11.4. Oncology
8.11.4.1. Cytotoxic Agents
8.11.4.2. Targeted Therapies
8.11.5. Pain Management
8.11.5.1. Non-Opioids
8.11.5.2. Opioids
9. Americas Generic Injectables Market
9.1. Introduction
9.2. United States
9.3. Canada
9.4. Mexico
9.5. Brazil
9.6. Argentina
10. Europe, Middle East & Africa Generic Injectables Market
10.1. Introduction
10.2. United Kingdom
10.3. Germany
10.4. France
10.5. Russia
10.6. Italy
10.7. Spain
10.8. United Arab Emirates
10.9. Saudi Arabia
10.10. South Africa
10.11. Denmark
10.12. Netherlands
10.13. Qatar
10.14. Finland
10.15. Sweden
10.16. Nigeria
10.17. Egypt
10.18. Turkey
10.19. Israel
10.20. Norway
10.21. Poland
10.22. Switzerland
11. Asia-Pacific Generic Injectables Market
11.1. Introduction
11.2. China
11.3. India
11.4. Japan
11.5. Australia
11.6. South Korea
11.7. Indonesia
11.8. Thailand
11.9. Philippines
11.10. Malaysia
11.11. Singapore
11.12. Vietnam
11.13. Taiwan
12. Competitive Landscape
12.1. Market Share Analysis, 2024
12.2. FPNV Positioning Matrix, 2024
12.3. Competitive Analysis
12.3.1. Fresenius Kabi AG
12.3.2. Baxter International Inc.
12.3.3. Pfizer Inc.
12.3.4. Sandoz International GmbH
12.3.5. Teva Pharmaceutical Industries Limited
12.3.6. Hikma Pharmaceuticals PLC
12.3.7. Viatris Inc.
12.3.8. Amneal Pharmaceuticals Inc.
12.3.9. Aspen Pharmacare Holdings Limited
12.3.10. Recipharm AB
13. ResearchAI
14. ResearchStatistics
15. ResearchContacts
16. ResearchArticles
17. Appendix
List of Figures
FIGURE 1. GENERIC INJECTABLES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENERIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 8. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 10. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. EUROPE, MIDDLE EAST & AFRICA GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. ASIA-PACIFIC GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GENERIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 16. GENERIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 17. GENERIC INJECTABLES MARKET: RESEARCHAI
FIGURE 18. GENERIC INJECTABLES MARKET: RESEARCHSTATISTICS
FIGURE 19. GENERIC INJECTABLES MARKET: RESEARCHCONTACTS
FIGURE 20. GENERIC INJECTABLES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENERIC INJECTABLES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENERIC INJECTABLES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENERIC INJECTABLES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACY DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACY DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY B2C PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY B2C PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY E-PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY E-PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RETAIL DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RETAIL DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY EMULSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY EMULSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANESTHETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY BETA-LACTAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY BETA-LACTAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GLYCOPEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY GLYCOPEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CYTOTOXICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CYTOTOXICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY END USER, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY END USER, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY BAG, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY BAG, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY BOTTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY BOTTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CEFUROXIME, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CEFUROXIME, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY FENTANYL, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY FENTANYL, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MEROPENEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MEROPENEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY OXALIPLATIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY OXALIPLATIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VANCOMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VANCOMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMPOULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARTRIDGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMPOULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY AMPOULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SAFETY SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SAFETY SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY STANDARD SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY STANDARD SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANESTHESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CYTOTOXIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY CYTOTOXIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 181. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 182. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 183. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. GLOBAL GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS GENERIC INJECTABLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 265. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 266. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 267. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 268. UNITED STATES GENERIC INJECTABLES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 269. CANADA GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 270. CANADA GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 271. CANADA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. CANADA GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. CANADA GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2018-2024 (USD MILLION)
TABLE 274. CANADA GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2025-2030 (USD MILLION)
TABLE 275. CANADA GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 276. CANADA GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 277. CANADA GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 278. CANADA GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 279. CANADA GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 280. CANADA GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 281. CANADA GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2018-2024 (USD MILLION)
TABLE 282. CANADA GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2025-2030 (USD MILLION)
TABLE 283. CANADA GENERIC INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. CANADA GENERIC INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. CANADA GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 286. CANADA GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 287. CANADA GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2018-2024 (USD MILLION)
TABLE 288. CANADA GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2025-2030 (USD MILLION)
TABLE 289. CANADA GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 290. CANADA GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, 2025-2030 (USD MILLION)
TABLE 291. CANADA GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 292. CANADA GENERIC INJECTABLES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 293. CANADA GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, 2018-2024 (USD MILLION)
TABLE 294. CANADA GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, 2025-2030 (USD MILLION)
TABLE 295. CANADA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. CANADA GENERIC INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. CANADA GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 298. CANADA GENERIC INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 299. CANADA GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. CANADA GENERIC INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. CANADA GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. CANADA GENERIC INJECTABLES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. CANADA GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, 2018-2024 (USD MILLION)
TABLE 304. CANADA GENERIC INJECTABLES MARKET SIZE, BY ANTI-INFECTIVE, 2025-2030 (USD MILLION)
TABLE 305. CANADA GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 306. CANADA GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 307. CANADA GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 308. CANADA GENERIC INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 309. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2018-2024 (USD MILLION)
TABLE 310. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DIMENSION QUERY CHAT SEGMENTATION, 2025-2030 (USD MILLION)
TABLE 311. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. MEXICO GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2018-2024 (USD MILLION)
TABLE 314. MEXICO GENERIC INJECTABLES MARKET SIZE, BY ONLINE DISTRIBUTION, 2025-2030 (USD MILLION)
TABLE 315. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 316. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 317. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 318. MEXICO GENERIC INJECTABLES MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 319. MEXICO GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 320. MEXICO GENERIC INJECTABLES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 321. MEXICO GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2018-2024 (USD MILLION)
TABLE 322. MEXICO GENERIC INJECTABLES MARKET SIZE, BY ONCOLOGY AGENTS, 2025-2030 (USD MILLION)
TABLE 323. MEXICO GENERIC INJECTABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. MEXICO GENERIC INJECTABLES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. MEXICO GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 326. MEXICO GENERIC INJECTABLES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 327. MEXICO GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2018-2024 (USD MILLION)
TABLE 328. MEXICO GENERIC INJECTABLES MARKET SIZE, BY LARGE VOLUME PARENTERAL, 2025-2030 (USD MILLION)
TABLE 329. MEXICO GENERIC INJECTABLES MARKET SIZE, BY MOLECULE, 2018-2024 (USD MILLION)
TABLE 330. MEXICO GENERIC INJECTABLES MARKET SIZE, BY MOLECU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Generic Injectables market report include:
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Pfizer Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Limited
  • Hikma Pharmaceuticals PLC
  • Viatris Inc.
  • Amneal Pharmaceuticals Inc.
  • Aspen Pharmacare Holdings Limited
  • Recipharm AB

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 40.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 67.3 Billion
Compound Annual Growth Rate10.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Generic Injectables Market Report 2025-2033 - Product Image

Generic Injectables Market Report 2025-2033

  • Report
  • 125 Pages
  • Global
From
Generic Injectables - Global Strategic Business Report - Product Image

Generic Injectables - Global Strategic Business Report

  • Report
  • 602 Pages
  • Global
From
Generic Injectables: Market Share, and Growth Analysis by Product Type (Powder Injectables, Liquid Injectables, Pre-filled Syringes), Application, End User, Technology - Product Image

Generic Injectables: Market Share, and Growth Analysis by Product Type (Powder Injectables, Liquid Injectables, Pre-filled Syringes), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Generic Injectables Market Report and Forecast 2025-2034 - Product Image

Generic Injectables Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Generic Injectables Market Report 2025 - Product Image

Generic Injectables Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Generic Injectable Market

The Generic Injectable market is a segment of the drug delivery industry that focuses on the production and distribution of generic injectable drugs. These drugs are typically administered via injection and are used to treat a variety of medical conditions. Generic injectables are typically cheaper than their branded counterparts, making them a popular choice for patients and healthcare providers alike. Generic injectables are typically produced in bulk and then packaged and distributed to pharmacies and hospitals. The production process involves the use of sterile manufacturing techniques and quality control measures to ensure the safety and efficacy of the drugs. Generic injectables are an important part of the drug delivery industry, as they provide an affordable and effective way to treat a variety of medical conditions. Some companies in the Generic Injectable market include Hospira, Mylan, Teva Pharmaceuticals, Sandoz, and Fresenius Kabi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.